⏳ Fetching live dividend data...
Home › Calculator › SEEL Dividend Calculator 2026
Seelos Therapeutics, Inc. · NASDAQ
Price: $0.37 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SEEL → $1162696.11M in 10 years · $81,764,845,985.91/month
Seelos Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to the discovery, development, and eventual commercialization of innovative therapies. These treatments primarily target central nervous system (CNS), respiratory, and various other medical conditions. The company's pipeline includes several key clinical-stage candidates. Foremost among these is SLS-002, an intranasally administered racemic ketamine, being investigated for rapidly alleviating acute suicidal ideation and behavior in individuals with major depressive disorder (MDD). Another significant program, SLS-005, acts as a protein stabilizer, addressing amyotrophic lateral sclerosis (ALS) and Sanfilippo syndrome. Additionally, SLS-006 is a partial dopamine agonist under development for the treatment of Parkinson's disease (PD). Beyond its clinical efforts, Seelos maintains a robust preclinical portfolio exploring novel mechanisms. This includes SLS-007, an anti-alpha-synuclein peptidic inhibitor designed to combat Parkinson's disease, and SLS-008, an orally bioavailable antagonist targeting chemoattractant receptor-homologous molecule, intended for chronic inflammatory conditions such as asthma and specific pediatric orphan diseases. Other early-stage candidates comprise SLS-004 for Parkinson's disease; SLS-010, an oral histamine H3A receptor antagonist aimed at narcolepsy and related sleep disorders; and SLS-012, an injectable formulation for managing post-operative pain. Founded in 1987, Seelos Therapeutics, Inc. operates from its headquarters situated in New York, New York.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SEEL position with:
Real after-tax yield depends on where you live and how you hold SEEL.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 540.54% | 537.74% | $54,054 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 459.46% | 456.66% | $45,946 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 432.43% | 429.63% | $43,243 / yr |
| 🇬🇧 UK ISA | 0% | 540.54% | 537.74% | $54,054 / yr |
| 🇬🇧 UK Taxable | 8.75% | 493.24% | 490.44% | $49,324 / yr |
| 🇨🇦 TFSA | 0% | 540.54% | 537.74% | $54,054 / yr |
| 🇨🇦 CA Taxable | 25% | 405.40% | 402.60% | $40,541 / yr |
| 🇦🇺 Super (pension) | 15% | 459.46% | 456.66% | $45,946 / yr |
| 🇦🇺 AU Taxable | 30% | 378.38% | 375.58% | $37,838 / yr |
| 🇩🇪 DE Taxable | 26.375% | 397.97% | 395.17% | $39,797 / yr |
| 🇫🇷 FR Taxable | 30% | 378.38% | 375.58% | $37,838 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SEEL pays quarterly — 4 times per year. Next ex-div: TBD.
How SEEL compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SEEL sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2024-02-29 | 417 | $1.10 | $457.00 | ||
| A-Award | 2024-01-12 | 70,383 | $1.41 | $99.2K | ||
| A-Award | 2024-01-12 | 24,537 | $1.41 | $34.6K | ||
| A-Award | 2024-01-04 | 1,666 | $1.33 | $2.2K | ||
| A-Award | 2024-01-04 | 1,666 | $1.33 | $2.2K | ||
| A-Award | 2024-01-04 | 1,666 | $1.33 | $2.2K | ||
| A-Award | 2024-01-04 | 1,666 | $1.33 | $2.2K | ||
| Buy | 2023-11-30 | 83,000 | $1.21 | $100.2K | ||
| Buy | 2023-12-01 | 75,757 | $1.32 | $100.0K | ||
| Buy | 2023-12-01 | 75,757 | $1.32 | $100.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SEEL dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Seelos Therapeutics, Inc. (SEEL) is currently trading at $0.37, trading near its 52-week low. The current dividend yield is 540.54% based on an annual payout of $2.00 per share.
Seelos Therapeutics, Inc. (SEEL) is a healthcare stock currently trading at $0.37 with a dividend yield of 540.54%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever